POV /

Engineering Biology

Investing in Engineering Biology to transform human and planetary health.

Endpoint

POV /

Engineering Biology

Investing in Engineering Biology to transform human and planetary health.

Nesos

POV /

Engineering Biology

Investing in Engineering Biology to transform human and planetary health.

We invest in exceptional people whose mission in life is to create a better world for our generation and the next ones.

We have served as early investors to iconic biotech and healthIT entrepreneurs for over 50 years including Amgen, Genentech, Heartstream, Intuitive Surgical, Millennium Pharmaceuticals and Mammoth Biosciences. The ability to marry the engineering approaches of information technology with advances in biology will re-invent trillion dollar industries and transform human and planetary health. 

Reversing climate change and preserving humanity is the greatest task of our generation, and also presents the greatest entrepreneurial opportunity in history. By using biology as a technology to reinvent production of the food we eat, the clothes we wear and the places we live and work in, we have a path to zero carbon footprint societies.

We invest across the engineering biology innovation loop from digitizing data, through developing platforms, to delivering applications.
Engineering Biology Pillars Graphic

POV

Article | Apr 27 2021

Mirvie Wants to Bring Liquid Biopsy Tech to ...

Engineering Biology | News

Video | Apr 26 2021

Scientist Entrepreneurs – Scaling Breakout Engineering Biology Companies

Engineering Biology

Viewpoint | Dec 10 2020

The Nēsos Journey

Engineering Biology | News

Viewpoint | Dec 9 2020

Engineering Biology: Five Silver Linings from 2020

Engineering Biology

Viewpoint | Nov 2 2020

Decoding the World: A Roadmap for the Questioner

Engineering Biology

Video | Oct 23 2020

Ursheet Shares Engineering Biology Investment Trends at SynBioBeta ...

Engineering Biology

Video | Oct 22 2020

Ursheet Shares his Perspective on Neuromodulation at SynBioBeta ...

Engineering Biology

Article | Oct 7 2020

Jennifer Doudna Wins Nobel Prize for CRISPR Discovery

Engineering Biology | News

Article | Sep 20 2020

Arvind Gupta’s Jiu Jitsu Makes Biotech Move at ...

Engineering Biology

Podcast | Aug 27 2020

Funding Biology with Conscious Capital to Save the ...

Conscious Capital | Engineering Biology

Article | Aug 13 2020

Mission Bio Raises $70M Series C

Engineering Biology | News

Viewpoint | Aug 1 2020

The $100 Trillion Opportunity

Engineering Biology

Podcast | Jul 26 2020

Designing Science with Arvind Gupta & Alex Lorestani

Engineering Biology

Viewpoint | Jul 15 2020

Investing in Human and Planetary Evolution

Conscious Capital | Engineering Biology | News

Viewpoint | Jul 13 2020

Endpoint Health: Partnering with Founders Building the Precision ...

Engineering Biology | News

Viewpoint | Jun 22 2020

The Secrets Behind Built-to-Last Companies

Engineering Biology

Viewpoint | Jun 22 2020

Three Post-Pandemic Areas of Opportunity in Digital Health ...

Engineering Biology

Viewpoint | Jun 22 2020

Portfolio Spotlight: Mammoth Biosciences

Engineering Biology

Viewpoint | Jun 10 2020

Engineering Biology Company Building

Engineering Biology | Company Building

Article | Jun 5 2020

Jennifer Doudna Shares How COVID-19 is Spurring Science ...

Engineering Biology

Video | May 19 2020

Evidence-Based Care, the Role of the AMA, and ...

Engineering Biology

Video | May 19 2020

Innovations in Care Delivery for Critical Conditions

Engineering Biology

Video | May 19 2020

The Secrets Behind Built-to-Last Companies

Engineering Biology

Video | May 19 2020

The Largest Post-Market Study on the Drugs that ...

Engineering Biology

Video | May 19 2020

The Role of the FDA in Enabling Healthcare ...

Engineering Biology

Article | May 13 2020

The New Diagnostics Marketplace in a Post-COVID-19 World

Engineering Biology

Video | Apr 14 2020

Create Capacity for COVID-19

Engineering Biology

Article | Apr 9 2020

Investing in Times of Turmoil, Neurotech and Happiness

Engineering Biology

Viewpoint | Apr 5 2020

Innovators Accelerating Delivery of COVID-19 Solutions

Engineering Biology

Viewpoint | Apr 1 2020

Health Innovator Summit Ebook

Engineering Biology

Article | Mar 13 2020

Qventus Offers a Solution for Hospitals to Predict ...

Engineering Biology

Viewpoint | Jan 30 2020

Enabling the Next Generation of CRISPR Products

Engineering Biology | News

Article | Dec 2 2019

Digitizing Biology and Scaling Precision Medicine Companies

Engineering Biology

Viewpoint | Sep 24 2019

Biology as Technology Will Reinvent Trillion Dollar Industries

Engineering Biology

Viewpoint | Jul 29 2019

Shaping the Future with Mission Bio’s Internship Program

Engineering Biology | Company Building

Article | Jul 23 2019

Synthetic Biology Investing in an Age of Open ...

Engineering Biology

Viewpoint | Jul 15 2019

Key Takeaways & Predictions from Health Evolution Summit ...

Engineering Biology

Video | Jun 11 2019

How to Create Jobs while Saving Lives

Engineering Biology

Article | Mar 5 2019

The Four Key Elements to Scaling Health IT ...

Engineering Biology | Company Building

Video | Jan 20 2019

Mammoth Biosciences CEO Trevor Martin & Ursheet Parikh ...

Engineering Biology

Viewpoint | Jan 15 2019

Accelerating Planetary Health

Engineering Biology

Video | Jan 2 2019

Designing Science with Arvind Gupta & Ursheet Parikh

Engineering Biology

Viewpoint | Dec 19 2018

The Biggest Threat to America is the Biggest ...

Engineering Biology

Article | Dec 13 2018

Mission Bio Raises $30 Million in Series B ...

Engineering Biology | News

Video | Oct 21 2018

Ursheet Parikh Shares Perspective on Precision Health

Engineering Biology

Viewpoint | Oct 3 2018

Building Synthetic Biology Companies at Scale

Engineering Biology | Company Building

Article | Sep 20 2018

Bio-Platforms: The Future of Innovation and Collaboration

Engineering Biology

Article | Jul 31 2018

Mammoth Biosciences Raises $23 Million for its CRISPR-based ...

Engineering Biology | News

Viewpoint | Jul 31 2018

CRISPR and the Precision Medicine Revolution

Engineering Biology | News

Viewpoint | Jun 19 2018

Healthcare Takes Center Stage At Mayfield Reception

Engineering Biology

Viewpoint | Dec 14 2017

Navin Chaddha on the Journey with Brighter

Enterprise | Engineering Biology | News

Viewpoint | Oct 12 2017

Mission Bio Delivers on the Promise of Precision ...

Engineering Biology | News

Viewpoint | Sep 18 2017

Ursheet Parikh Hosts Discussion on Digital Health Trends

Engineering Biology

Article | Jul 26 2017

A People-First View of Investing in Innovation

Enterprise | Consumer | Engineering Biology

Viewpoint | May 1 2017

Mayfield’s Ursheet and Tim Share Their POV on ...

Engineering Biology

Entrepreneur Journey | Mar 20 2017

Three Pivots to Better Healthcare

Engineering Biology | Gamechangers

Article | Mar 16 2017

Mayfield’s Parikh on What Makes Digital Health Startups ...

Engineering Biology

Viewpoint | Jan 9 2017

6 Reasons Why Digital Health Startups Will Fail

Engineering Biology | Company Building

Viewpoint | Jul 26 2014

Start-ups are finally hacking healthcare

Engineering Biology

Non-obvious Insights from Healthcare Innovators

Get a deep look at non-obvious insights from healthcare innovators, shared at previous Mayfield gatherings.

Investments

NASDAQ: AMGN

Former NASDAQ: APPB

Acquired by Intel

Acquired by Cigna

Former NYSE: GENE

Acquired by HP

NASDAQ: ISRG

Millenium Pharmaceuticals logo

Former NASDAQ: MLNM

NASDAQ: SCTY / Acquired by Tesla

IPO India: SUZLON.NS - Pre-Mayfield Investment

Engineering Biology Team

Ursheet Parikh

Ursheet Parikh

Read Bio

Ursheet Parikh

Ursheet Parikh

Ursheet co-leads Mayfield’s Engineering Biology investment practice where Mayfield invests in companies transforming human and planetary health.

His investments in engineering biology and healthcare include Mammoth Biosciences (CRISPR), Mission Bio (Single Cell Sequencing, Oncology), Qventus (Healthcare AI), Endpoint Health (Critical hospital care), Nēsos (Immunology, Neurology) and an unannounced company in precision diagnostics for maternal and fetal health in Healthcare & Engineering Biology.

Prior to Mayfield, Ursheet had an operating career as a proven repeat entrepreneur and executive at Cisco and Microsoft. Ursheet was co-founder & CEO of StorSimple – the leading cloud-integrated storage company that was acquired by Microsoft in 2012.

Ursheet holds an MBA from the Wharton School and a Bachelors in Computer Science from the Indian Institute of Technology in Mumbai, from which he received the Young Alumni Achiever award in 2015.

Ursheet is passionate about accelerating healthcare innovation and transforming college education where his family foundation is focused.

Full Bio
Arvind Gupta

Arvind Gupta

Read Bio

Arvind Gupta

Arvind Gupta

Arvind Gupta co-leads Mayfield’s Engineering Biology practice whose mission is to invest in science based companies that could change history. Ranging from reinventing our food system to stopping climate change to novel therapeutics, Arvind was the first investor in breakout companies such as Geltor,Synthex, Prime Roots, NotCo, Prellis, New Culture, DNA Lite, Catalog, Prellis and Memphis Meats.

As Founder of IndieBio, Arvind redefined the pace and possibilities of early stage biotech, investing in over 136 companies in five years, defining human and planetary health, and growing the IndieBio portfolio into billions of dollars in value. Under his leadership, IndieBio expanded to New York and grew to fifteen investment professionals with a world renowned adjunct partner board. He now serves as Venture Advisor at IndieBio.

Arvind is the author of Decoding the World: A Roadmap for the Questioner, published by Twelve Books, a division of the Hachette Publishing Group. He was honored with the F50 Global Award for Impact in HealthTech Innovation. He is a frequent speaker at TechCrunch Disrupt, Slush, TedX and Future FoodTech. His work has been profiled in global media outlets such as Bloomberg News, Forbes, The Guardian UK, Neo.life, Nikkei News, Rotman, The Times of India, and CGTN in China. Arvind has been a guest lecturer at UCSF, MIT and Harvard and is a judge at the annual BIO conference startup stadium.

Prior to founding IndieBio, Arvind was Design Director at IDEO in Shanghai where he earned numerous international design awards and presented his work at the San Francisco Museum of Modern Art. He was also a BASE jumper and big wall climber and now fights professional grappling.

Arvind received his B.S. in Genetic Engineering from UCSB. He holds 8 patents.

Arvind is married to an Icelander and has two daughters.

Full Bio
Navin Chaddha

Navin Chaddha

Read Bio

Tim Chang

Tim Chang

Read Bio

Tim Chang

Tim Chang

Tim is an experienced investor and global executive. He has been twice named to the Forbes Midas list of Top Tech Investors and received the Gamification Summit award for Special Achievement. Tim’s venture capital experience includes leading investments at Norwest Venture Partners and Gabriel Venture Partners. His operational experience includes working in product management and engineering across Asia for Gateway, Inc., and General Motors. Tim holds an MBA with honors from the Stanford Graduate School of Business, and an MS and BS in Electrical Engineering/System Engineering from the University of Michigan. Tim is an accomplished musician, a reformed biohacker, and passionate about Body/Mind/Spirit wellness. He serves on the non-profit boards of Reimagine Death, and Gray Area Arts.

Full Bio